Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling

Gang Cao, Ruyi Zhu, Ting Jiang, Dongxin Tang, Hiu Yee Kwan, Tao Su*

*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

31 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Danshensu, a novel indoleamine 2,3-dioxygenase1 inhibitor, exerts anti-hepatic fibrosis effects via inhibition of JAK2-STAT3 signaling'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science